Monday, November 25, 2024
HomeTagsMagnetic resonance imaging

magnetic resonance imaging

Genentech’s BTK Inhibitor Fenebrutinib Significantly Reduced Brain Lesions in People With Relapsing Forms of Multiple Sclerosis

Genentech, a member of the Roche Group , announced positive results from the Phase II FENopta study evaluating investigational oral fenebrutinib in adults with...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics